▶️ Watch in full here: Thank you to the community for your ongoing strength – your voices and experiences are driving science forward. #SevereMEDay #MECFS #LongCOVID #PrecisionMedicine #Genomics #ClinicalTrials #DrugRepurposing #MyalgicE.

🎥 As part of today’s recognition of #SevereME, we’re sharing this recent presentation by our Co-founder, Rowan Gardner, given at International ME Conference: 𝗣𝗿𝗲𝗰𝗶𝘀𝗶𝗼𝗻 𝗗𝗶𝗮𝗴𝗻𝗼𝘀𝘁𝗶𝗰 𝗧𝗲𝘀𝘁𝘀 𝗮𝗻𝗱 𝗣𝗲𝗿𝘀𝗼𝗻𝗮𝗹𝗶𝘇𝗲𝗱 𝗧𝗿𝗲𝗮𝘁𝗺𝗲𝗻𝘁𝘀 𝗳𝗼𝗿 𝗠𝗘.

We are now running 𝗰𝗹𝗶𝗻𝗶𝗰𝗮𝗹 𝘁𝗿𝗶𝗮𝗹𝘀 𝗶𝗻 𝘁𝗵𝗲 𝗨𝗦 to validate new non-invasive diagnostic and therapeutic options – a major step toward faster diagnosis, targeted care, and hope for millions of patients.

Thanks to you, we’ve:.✔️ Confirmed the 𝗳𝗶𝗿𝘀𝘁-𝗲𝘃𝗲𝗿 𝗴𝗲𝗻𝗲𝘁𝗶𝗰 𝗲𝘃𝗶𝗱𝗲𝗻𝗰𝗲 for ME/CFS and long COVID.✔️ Identified 𝘀𝗵𝗮𝗿𝗲𝗱 𝗱𝗶𝘀𝗲𝗮𝘀𝗲 𝗺𝗲𝗰𝗵𝗮𝗻𝗶𝘀𝗺𝘀 between both conditions.✔️ Discovered genes that 𝗿𝗲𝘀𝗶𝘀𝘁 𝗮𝗻𝗱 𝗽𝗿𝗼𝘁𝗲𝗰𝘁 against ME.

We are deeply grateful to the ME community whose participation in research has enabled ground-breaking progress in understanding this long-neglected condition so that new diagnostic tools and drug treatment can be developed with greater clarity.

𝗧𝗼𝗱𝗮𝘆 𝗶𝘀 𝗦𝗲𝘃𝗲𝗿𝗲 𝗠𝗘 𝗗𝗮𝘆 – a moment to acknowledge the strength, resilience, and determination of those living with the most debilitating forms of Myalgic Encephalomyelitis.

Millions are still waiting for answers. Ahead of #SevereMEAwarenessDay, we’re reaffirming our support and using genetic insights to develop the first non-invasive mechanostic tests to accelerate diagnosis and improve care. 🔗 #MECFS #LongCOVID

On this Global MND Awareness Day, we're sharing our latest work uncovering the mechanisms behind ALS, new protective biology, and a path to non-invasive, personalized diagnosis and treatment. Read more: #ALS #MND

⏰ Last chance to register!. Our webinar on #MECFS & #LongCOVID is tomorrow. Join for the latest research insights and their implications for the prediction, treatment and prevention of the conditions. 🔗 Register: #pwME #MyalgicE #MillionsMissing

Join the free webinar hosted by @actionforme on 6 June to hear the latest genetic research on ME/CFS & Long COVID and what it means for patients, clinical practice, and the future of precision medicine. 🔗 . #MECFS #LongCOVID

🎥 𝗘𝘅𝗽𝗲𝗿𝘁 𝗣𝗿𝗲𝘀𝗲𝗻𝘁𝗮𝘁𝗶𝗼𝗻:.We highly recommend watching Dr. Sayoni Das' presentation, #PrecisionMedicine for Long COVID and ME/CFS. 👉 𝗪𝗮𝘁𝗰𝗵 𝗵𝗲𝗿𝗲:

𝗚𝗲𝗻𝗲𝘁𝗶𝗰 𝗥𝗶𝘀𝗸 𝗙𝗮𝗰𝘁𝗼𝗿𝘀 𝗳𝗼𝗿 𝗦𝗲𝘃𝗲𝗿𝗲 𝗮𝗻𝗱 𝗙𝗮𝘁𝗶𝗴𝘂𝗲 𝗗𝗼𝗺𝗶𝗻𝗮𝗻𝘁 #𝗟𝗼𝗻𝗴𝗖𝗢𝗩𝗜𝗗 𝗮𝗻𝗱 𝗖𝗼𝗺𝗺𝗼𝗻𝗮𝗹𝗶𝘁𝗶𝗲𝘀 𝘄𝗶𝘁𝗵 #𝗠𝗘𝗖𝗙𝗦: 73 novel genes associated with Long COVID, and shared mechanisms with ME/CFS.

📄 𝗥𝗲𝘀𝗲𝗮𝗿𝗰𝗵 𝗛𝗶𝗴𝗵𝗹𝗶𝗴𝗵𝘁𝘀:.𝗚𝗲𝗻𝗲𝘁𝗶𝗰 𝗥𝗶𝘀𝗸 𝗙𝗮𝗰𝘁𝗼𝗿𝘀 𝗳𝗼𝗿 #𝗠𝗘𝗖𝗙𝗦 𝗜𝗱𝗲𝗻𝘁𝗶𝗳𝗶𝗲𝗱 𝘂𝘀𝗶𝗻𝗴 𝗖𝗼𝗺𝗯𝗶𝗻𝗮𝘁𝗼𝗿𝗶𝗮𝗹 𝗔𝗻𝗮𝗹𝘆𝘀𝗶𝘀: 14 novel genetic associations, paving the way for precision medicine.

Through our innovative AI-led combinatorial analytics platform, we've identified the first reproducible genetic associations for these complex conditions, offering hope for millions affected worldwide.

🔬 𝗠𝗘 𝗔𝘄𝗮𝗿𝗲𝗻𝗲𝘀𝘀 𝗪𝗲𝗲𝗸 𝗦𝗽𝗼𝘁𝗹𝗶𝗴𝗵𝘁: 𝗣𝗶𝗼𝗻𝗲𝗲𝗿𝗶𝗻𝗴 𝗥𝗲𝘀𝗲𝗮𝗿𝗰𝗵 𝗶𝗻 𝗠𝗘/𝗖𝗙𝗦 𝗮𝗻𝗱 𝗟𝗼𝗻𝗴 𝗖𝗢𝗩𝗜𝗗. This #MEAwarenessWeek, we're proud to share our progress in understanding and treating #MECFS and #LongCOVID. 🔗

RT @MalnutritionME: Among 491 patients with #SevereME:. 13% had gastrostomy.17% were tube fed .20% could sometimes eat.37% had nausea hinde….

#PrecisionMedicine #MECFS #pwME #MyalgicE #MyalgicEncephalomyelitis #ThereForME #WorldMEDay2025.

This is precision medicine in action — made possible through our #LOCOME project and partnerships across the UK and US. 👉 Explore our first-year progress in this visual summary — and read the full report on our website:

We’re changing that. 🧬 We’ve identified novel genetic drivers of disease.🛡️ Discovered actively protective drug targets.🧪 Developed rapid, non-invasive diagnostic tools.💊 Initiated studies of repurposed, precision therapies.🎯 Enabled differential triage across syndromes.

More than 400 million people worldwide have these debilitating conditions — yet there are no accurate diagnostic tools or effective treatments to treat the underlying causes.